1. Home
  2. MMSI vs CWAN Comparison

MMSI vs CWAN Comparison

Compare MMSI & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMSI
  • CWAN
  • Stock Information
  • Founded
  • MMSI 1987
  • CWAN 2004
  • Country
  • MMSI United States
  • CWAN United States
  • Employees
  • MMSI N/A
  • CWAN 1915
  • Industry
  • MMSI Medical/Dental Instruments
  • CWAN Computer Software: Prepackaged Software
  • Sector
  • MMSI Health Care
  • CWAN Technology
  • Exchange
  • MMSI Nasdaq
  • CWAN Nasdaq
  • Market Cap
  • MMSI 5.8B
  • CWAN 6.1B
  • IPO Year
  • MMSI 1990
  • CWAN 2021
  • Fundamental
  • Price
  • MMSI $95.03
  • CWAN $23.09
  • Analyst Decision
  • MMSI Buy
  • CWAN Buy
  • Analyst Count
  • MMSI 9
  • CWAN 9
  • Target Price
  • MMSI $109.11
  • CWAN $32.44
  • AVG Volume (30 Days)
  • MMSI 611.3K
  • CWAN 3.1M
  • Earning Date
  • MMSI 04-24-2025
  • CWAN 04-30-2025
  • Dividend Yield
  • MMSI N/A
  • CWAN N/A
  • EPS Growth
  • MMSI 17.19
  • CWAN N/A
  • EPS
  • MMSI 2.04
  • CWAN 1.71
  • Revenue
  • MMSI $1,388,357,000.00
  • CWAN $475,948,000.00
  • Revenue This Year
  • MMSI $11.31
  • CWAN $63.48
  • Revenue Next Year
  • MMSI $6.09
  • CWAN $29.35
  • P/E Ratio
  • MMSI $46.61
  • CWAN $13.48
  • Revenue Growth
  • MMSI 8.19
  • CWAN 23.21
  • 52 Week Low
  • MMSI $80.02
  • CWAN $17.63
  • 52 Week High
  • MMSI $111.45
  • CWAN $35.71
  • Technical
  • Relative Strength Index (RSI)
  • MMSI 46.91
  • CWAN 49.23
  • Support Level
  • MMSI $93.86
  • CWAN $21.79
  • Resistance Level
  • MMSI $97.18
  • CWAN $22.66
  • Average True Range (ATR)
  • MMSI 1.85
  • CWAN 0.57
  • MACD
  • MMSI -0.20
  • CWAN -0.02
  • Stochastic Oscillator
  • MMSI 18.48
  • CWAN 45.86

About MMSI Merit Medical Systems Inc.

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

About CWAN Clearwater Analytics Holdings Inc.

Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.

Share on Social Networks: